J-PDX Library > Achievements

Achievements

  1. Therapeutic target biomarkers of patient-derived xenograft models of gastric-type cervical adenocarcinoma. Yuki Kojima, Hiroshi Yoshida, Toshihiro Okuya, Hitomi S Okuma, Tadaaki Nishikawa, Maki Tanioka, Kazuki Sudo, Emi Noguchi, Tatsunori Shimoi, Kenji Tamura, Yasuhito Tanase, Masaya Uno, Mitsuya Ishikawa, Motoko Arakaki, Hitoshi Ichikawa, Shigehiro Yagishita, Akinobu Hamada, Yasuhiro Fujiwara, Kan Yonemori, Tomoyasu Kato. Gynecol Oncol Rep. 2023 Nov 14:50:101302
  2. Fucoxanthin Inhibits Development of Sigmoid Colorectal Cancer in a PDX Model With Alterations of Growth, Adhesion, and Cell Cycle Signals. Masaru Terasaki, Kirara Tsuruoka, Takuji Tanaka, Hayato Maeda, Masaki Shibata, Kazuo Miyashita, Yukihide Kanemitsu, Shigeki Sekine, Mami Takahashi, Shigehiro Yagishita, Akinobu Hamada. Cancer Genomics Proteomics. 2023 Dec;20(6suppl):686-705.
  3. Co-Clinical Study of [fam-] Trastuzumab Deruxtecan (DS8201a) in Patient-Derived Xenograft Models of Uterine Carcinosarcoma and Its Association with Clinical Efficacy. Shigehiro Yagishita, Tadaaki Nishikawa, Hiroshi Yoshida, Daisuke Shintani, Sho Sato, Maiko Miwa,Mikiko Suzuki1, Masanori Yasuda, Yusuke Ogitani, Takahiro Jikoh, Kan Yonemori, Kosei Hasegawa and Akinobu Hamada. Clin Cancer Res 2023 OF1–OF11
  4. Development of an analytical method to determine E7130 concentration in mouse plasma by micro-sampling using ultra-performance liquid chromatography-high resolution mass spectrometry. Ryu S, Hayashi Y, Yagishita S, Takahashi A, Yokoi A, Ohuchi M, Hamada A. J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Sep 1;1207:123366.
  5. Comparative Study on the Efficacy and Exposure of Molecular Target Agents in Non-small Cell Lung Cancer PDX Models with Driver Genetic Alterations. Jo H, Yagishita S, Hayashi Y, Ryu S, Suzuki M, Kohsaka S, Ueno T, Matsumoto Y, Horinouchi H, Ohe Y, Watanabe SI, Motoi N, Yatabe Y, Mano H, Takahashi K, Hamada A. Mol Cancer Ther. 2022 Feb;21(2):359-370.
  6. Visualization of Intratumor Pharmacokinetics of [fam-] Trastuzumab Deruxtecan (DS-8201a) in HER2 Heterogeneous Model Using Phosphor-integrated Dots Imaging Analysis. Suzuki M, Yagishita S, Sugihara K, Ogitani Y, Nishikawa T, Ohuchi M, Teishikata T, Jikoh T, Yatabe Y, Yonemori K, Tamura K, Hasegawa K, Hamada A. Clin Cancer Res. 2021 Jul 15;27(14):3970-3979.
  7. Characterization of the large-scale Japanese patient-derived xenograft (J-PDX) library. Yagishita S, Kato K, Takahashi M, Imai T, Yatabe Y, Kuwata T, Suzuki M, Ochiai A, Ohtsu A, Shimada K, Nishida T, Hamada A, Mano H. Cancer Sci. 2021 Jun;112(6):2454-2466.